Sign in

CIK 0000949858 · Non-accelerated filer<br>Smaller reporting company

ACHIEVE LIFE SCIENCES, INC.

Sign in to watch
Tickers
ACHV QUIT
Exchange
Nasdaq
Industry
In Vitro & In Vivo Diagnostic Substances
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
954343413
Phone
425-686-1500
Business address
22722 29TH DR. SE, SUITE 100, SEATTLE, WA, 98021
Former names
ONCOGENEX PHARMACEUTICALS, INC., SONUS PHARMACEUTICALS INC

Securities

  • ACHV Common stock Nasdaq
  • QUIT Common Shares Nasdaq
  1. POS AM Other Post-effective Amendment for Registration Statement
  2. POS AM Other Post-effective Amendment for Registration Statement
  3. POS AM Other Post-effective Amendment for Registration Statement
  4. POS AM Other Post-effective Amendment for Registration Statement
  5. POS AM Other Post-effective Amendment for Registration Statement
  6. POS AM Other Post-effective Amendment for Registration Statement
  7. POS AM Other Post-effective Amendment for Registration Statement
  8. POS AM Other Post-effective Amendment for Registration Statement
  9. S-8 Other Securities Offered to Employees in Benefit Plans
  10. DEFA14A Proxy Proxy Materials
  11. DEFA14A Proxy Proxy Materials
  12. DEFA14A Proxy Proxy Materials
  13. 8-A12G/A Other 8-A12G/A
  14. DEFA14A Proxy Proxy Materials
  15. DEFA14A Proxy Proxy Materials
  16. DEFA14A Proxy Proxy Materials
  17. EFFECT Other Notice of Effectiveness
  18. S-8 Other Securities Offered to Employees in Benefit Plans
  19. 8-A12G/A Other 8-A12G/A
  20. S-8 Other Securities Offered to Employees in Benefit Plans

Page 5 of 7 · 123 filings